News

100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
Fierce Pharma16h
Another FDA mini-pause for Bayer’s menopause candidate?
After losing 3,500 employees in April—19% of its workforce due to congressional budget cuts—the FDA is now struggling to meet ...
FDA chief talks staffing, abortion drug and tobacco
The FDA is still on track to meet its user fee targets despite a higher-than-normal vacancy rate among scientific reviewers.
STAT22d
How an erosion of staff expertise threatens Marty Makary’s FDA | STAT
FDA employees are spooked by increasing political involvement in regulatory decisions, frustrated by the impact of cuts to administrative staff who supported drug reviews and inspections, and fed ...
Medical Xpress13d
Thousands laid off from NIH, FDA and CDC after Supreme Court decision
In total, HHS plans to cut about 20,000 jobs this year ... The Times reported. At the FDA, staff who coordinated ...
FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...
MM&M22d
FDA layoffs could compromise safety of medications made at foreign ...
Amid news reports describing the layoffs at the FDA, Kennedy did not specify how many people would be reinstated. ProPublica spoke to 10 current and former FDA staff members and leaders in recent ...
FDA Names Biotech Veteran George Tidmarsh To Lead Drug Evaluation Division
George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...
FDA Head Marty Makary on Food Dyes, Ultra-Processed Foods and the MAHA Agenda
The Food and Drug Administration commissioner reveals what health officials are prioritizing in a forthcoming report on childhood chronic disease.
Health Cuts Would Result in Fewer Drugs for Americans, Budget Office Reports
The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...
CBO finds health agency cuts would result in fewer new drugs
The Trump administration’s proposed cuts at the National Institutes of Health and Food and Drug Administration could lower ...
Opinion
FDA Commissioner: 100 Days of Change—Modernizing the FDA for a Healthier America | Opinion
The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and unnecessary delays in the regulatory process.